B&B Tools AB

SWF:NOVN ISIN:CH0012005267

Mit einem Umsatz von rund 2,8 Milliarden Euro im Jahr 2007 und einem Marktanteil von elf Prozent ist Novartis die umsatzstärkste Pharmaunternehmensgruppe im deutschen Gesundheitsmarkt. 
 
  

Sprache wählen

News

Novartis International AG (VTX:NOVN) Novartis Launches Extavia®, A New Therapeutic Option To Help Patients Combat Devastating Symptoms Of Multiple Sclerosis

🕔1/22/2009 5:17:00 PM 7216

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Four Innovative Novartis Medicines For Cancer, Asthma, High Blood Pressure And Wet AMD Approved In Japan

🕔1/21/2009 5:17:00 PM 3649

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) US Department Of Health And Human Services Awards Novartis USD 486 million Contract To Build Manufacturing Facility For Pandemic Flu Vaccine

🕔1/16/2009 2:03:00 AM 4283

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) New Study First To Confirm Sandostatin® LAR® Controls Tumor Growth In Patients With Rare Gastrointestinal Tumors

🕔1/14/2009 10:03:00 AM 5157

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Afinitor® Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More Prior Treatments

🕔1/14/2009 10:01:00 AM 4118

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Novartis Strengthens Vaccine Pipeline With Agreement For Novel CMV vaccines Candidate

🕔12/29/2008 5:17:00 PM 3158

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Glivec Receives US Approval As First Treatment To Reduce Risk Of Cancer Returning In Patients With Gastrointestinal Stromal Tumors

🕔12/20/2008 12:17:00 PM 11462

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Afinitor® Shows Potential To Reverse Resistance To Herceptin®[*] In Metastatic Breast Cancer Patients, Leading To Phase III Trial

🕔12/13/2008 10:03:00 AM 2833

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) First Phase III Results For FTY720, A Novel Oral Therapy For MS, Show Superior Efficacy Compared To Interferon Beta-1a

🕔12/12/2008 5:17:00 PM 2768

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) New Data Show Zometa® Enhances Impact Of Chemotherapy On Reducing Breast Tumor Size

🕔12/12/2008 7:03:00 AM 2637

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel
###

51,610 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 62) (letzten 30 Tagen: 220) (seit Veröffentlichung: 18071) 

Company Data

    Principal Sector
  • Gesundheit & Pharm 
  • Principal Industry
  • Pharmaceutical 
  • Homepage
  • www.novartis.de